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with a male: female sex ratio of 2.5: 1. Fungal culture 
was positive in 85.71% whereas AEC was increased 
in 42.86% cases. Microscopic evidence and antibody 
response was detectable in only 2 cases each (28.57%). 
None of the cases showed a positive skin response. 
Conclusions: It is emphasized that in the light of a strong 
clinical suspicion, a rigorous laboratory work up in the 
form of microscopy, culture and immunological studies 
is warranted for an early diagnosis and management of 
IA in order to avoid serious and fatal complications. 
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Background: Paecilomyces lilacinus is a rare oppor- 
tunistic pathogen in man and due to in vitro resistance 
to amphotericin B treatment is extremely difficult. 
Successful therapy with ketoconazole, itraconazole, 
and terbinafine has been sporadically reported although 
optimal treatment for serious infections due to I? lilacinus 
remains uncertain. 
Results: A cluster of red nodules developed in a 64-year- 
old diabetic woman with metastatic adenocarcinoma of 
the pancreas. In the following two weeks, an extensive 
area involving the right lower leg and isolated cluster of 
lesion in the medial mid-thigh were noticed. Six months 
earlier, she had received weekly gemcitabine (1000 
mg/m”). She also underwent multiple hospitalizations 
for severe asthma exacerbation requiring high-dose 
corticosteroides in the preceding three months. Extensive, 
excoriated nodules and pustules overlying erythematous 
and indurated base were present on examination of the 
right lower extremity. WBC 10.8 x lO?uL, creatinine 3.3 
mg/ml, LDH 389 U/L, AST 46 U/L, and ESR 16 mm/h. 
Blood cultures were sterile. No acute pulmonary process 
was seen on chest computed tomography scan. Within 
three days, prominent growth (5 to 10 colonies) of 
Paecilomyces lilacinus was isolated from several skin 
lesions. The in vitro antifungal susceptibility was deter- 
mined at two intervals (MIC (g/ml; 48 h and 72 h) 
and are as follows: amphotericin B 16.0 and 16.0, 
ketoconazole 1.0 and 1.0, itraconazole 1.0 and 4.0, 
voriconazole 0.25 and 0.25, posaconazole 0.125 and 
0.125, ravuconazole 0.5 and 1.0, and caspofungin 1.0 and 
4.0. Treatment with oral itraconazole 600 mg daily (for 
3 days) than 400 mg daily was initiated. Seven days later, 
caspofungin 70 mg, than 50 mg daily was added due to 
lack of clinical response. In the following week, 
excoriated nodules involving the mid-thigh, and lower 
leg resolved. No new pustules were noticed. Treatment 
was continued for four weeks, with complete resolution 
of the P lilacinus infection, and there were no significant 
side effects of the therapy. 
Conclusions: Since 1977, less than 25 cases of cutaneous 
Paecilomyces infection have been reported. Suscepti- 
bility to amphotericin B, flucytosine, triazole-based 
agents is variable and P lilacinus frequently shows in 
vitro resistance to the currently available agents. The in 
vitro susceptibility profiles of the newer, broad-spectrum 
triazoles appears to be promising, and treatment with 
combination antifungals in my patient lead to rapid 
clearing of infection. 
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Background: Most invasive Candida infection arises 
from hosts’ endogenous flora, and critically ill patients 
with prominent Candida colonization are considered at 
risk for near-future systemic invasion. This association in 
non-critically ill adults with cancer is unclear. 
Methods: During July 11998 to April 14 1999,193 patients 
with prominent colonization (~50 Candida colonies 
from nonsterile source) were evaluated prospectively, 
and followed for 14 weeks after the initial cultures. 
Results: Solid-organ cancer was most common (129) 
Cancer, 43 had hematological malignancies, and 17 
underwent allogeneic marrow graft transplantation. Six 
had AIDS, and 13 with benign conditions. Fifty-three 
(27.5%) patients expired, of these 25 (19.4%) had solid- 
organ cancer, 60.5% with hematological malignancy. 
Eleven (65%) marrow transplantation recipients died. 
No deaths were observed in patients with AIDS, and one 
in those with benign diseases. Among 53 that died, 26 
(49%) had respiratory tract colonization, 13 (24.5%) GI 
tract and 3 (5.7%) GU tract. Fifty percent with 22 body 
site colonization expired and all 4 patients (100%) with 
two respiratory tract sites died. Twenty-one percent died 
with a single site C. albicans colonization, and 53.8% 
with ~2 sites involved, similarly for C. glabrata 46.7% 
with single site, and 100% with multiple sites. Single site 
colonization and mortality was highest for C. krusei 
(75%), while in case of C. tropicalis (30%) and C. 
parapsilosis (25%) it was substantially lower. Four 
patients (18.2%) among those with r2 Candida species 
colonization expired, 100% mortality in patients with C. 
albicans+ C, krusei dual species colonization, while 20% 
in 10 patients with C. albicans+C. glabrata. NO short- 
term mortality was seen in patients with C. albicans + C. 
